Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Tetrahedron Lett. 2016 Apr 28;57(22):2347–2350. doi: 10.1016/j.tetlet.2016.04.020

Rapid cycloaddition of a diazo group with an unstrained dipolarophile

Matthew R Aronoff a,, Brian Gold a,, Ronald T Raines a,b,*
PMCID: PMC5125787  NIHMSID: NIHMS782800  PMID: 27909348

Abstract

The cycloaddition of a diazoacetamide with ethyl 4,4,4-trifluorocrotonate proceeds with k = 0.1 M−1s−1. This second-order rate constant rivals those of optimized strain-promoted azide– alkyne cycloadditions, even though the reaction does not release strain. The regioselectivity and a computational distortion/interaction analysis of the reaction energetics are consistent with the formation of an N–H…F–C hydrogen bond in the transition state and the electronic character of the trifluorocrotonate. Analogous reactions with an azidoacetamide dipole or with an acrylate or crotonate dipolarophile were much slower. These findings suggest a new strategy for the design of diazo-selective reagents for chemical biology.

Keywords: Diazo group; 1,3-Dipolar cycloaddition; (E)-Ethyl 4,4,4-trifluorobut-2-enoate; Hydrogen bond; Hyperconjugation

Graphical abstract

graphic file with name nihms782800u1.jpg

Introduction

The diazo group has the potential to be a valuable addition to the armamentarium of chemical biology. A complement to azido groups, diazo groups have been employed in many biochemical applications, including reversible1 and non-reversible protein alkylations,2 nucleic acid conjugation,3 and other bioconjugations.4 Extant strategies to install pendant diazo groups5 and to prepare them directly by deimidogenation of a parent azide6 facilitate their use.

Mistakenly believed to be too reactive for physiological investigations, a diazo moiety stabilized by electronic delocalization can tolerate metabolism while retaining reactivity.7 Nevertheless, the use and development of diazo compounds in chemical biology are constrained by a paucity of chemoselective reactions. Most confounding is the overlapping reactivity of the diazo group with that of the azido group in strain-promoted azide–alkyne cycloadditions (SPAACs).7,8

The need for reactions that are chemoselective in a biological context continues to grow.9 Recently, we explored 1,3-dipolar cycloadditions of diazo compounds in the presence of azides.10 Although we were able to achieve diazo group-specific conjugation in the absence of a catalyst (Scheme 1), the reaction rates were low—comparable to those obtained with early SPAAC reagents and exceeded by new SPAAC reagents.8c,11 Hence, we sought a faster cycloaddition.

Scheme 1. Chemoselective cycloaddition of a diazoacetamide with an acrylate ester.

Scheme 1

We were aware that fluoro groups can elicit favorable orbital interactions in cycloadditions12 and other reactions.13 Accordingly, we explored the utility of fluoro groups in a cycloaddition reaction with a diazo compound. We discovered that the reaction of a diazoacetamide with a fluorinated crotonate proceeds at an extraordinary rate. We used computations to provide insight into this rate acceleration. The results reveal a general strategy for the design of efficacious diazo-selective reagents for applications in chemical biology.

Results and discussion

In an initial screen of reactions, we dissolved N-benzyl-2-diazoacetamide (1) in 1:1 CH3CN/H2O and added ethyl 4,4,4-trifluorocrotonate (2) to the resulting solution (Scheme 2).14 We found that the diazo compound was consumed rapidly, as monitored with thin-layer chromatography. The reaction product had the mass of the pyrazoline that would result from the dipolar cycloaddition reaction of the diazo group and the alkene. We monitored the reaction by ultraviolet spectroscopy, and found the observed rate constant to be k = 0.105 M−1s−1. This rate constant is comparable to that of an azide with BARAC, which is the fastest known SPAAC reaction.15

Scheme 2. Rapid cycloaddition of a diazoacetamide with a 4,4,4-trifluorocronate ester, and product analysis.

Scheme 2

The putative pyrazoline product contained a mixture of isomers. We were able to purify the major product (3) and confirm its structure using 3 J coupling values from 1H-NMR spectroscopy as verified with heteronuclear multiple bond correlation (HMBC). Based on isolated yields, the cycloaddition occurred to produce 3 and 4 in a 9:1 ratio. This strong regiochemical preference for the anti orientation of the carbonyl groups is consistent with the π-acceptor ester group being a stronger electron-withdrawing substituent than is the σ-acceptor trifluoromethyl group and with the formation of an N–H···F–C hydrogen bond, as has been observed in other contexts.16

To verify the identity of products 3 and 4, we sought to oxidize the enantiomeric mixture of pyrazolines to their aromatic pyrazole equivalents.17 Attempts at oxidation with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) were unsuccessful, but treatment with Br2 produced the pyrazole product (Scheme 2). To confirm the assignment of pyrazolines 3 and 4, the oxidation products were compared to those resulting directly from the reaction of diazoacetamide 1 with ethyl 4,4,4-trifluorobut-2-ynoate (5). The 1H-NMR and 13C-NMR spectra of 6 and 7 produced by the two routes were indistinguishable.

Next, we confirmed the importance of electronic acceleration provided by allylic fluorination by assessing the cycloaddition of diazoacetamide 1 with ethyl acrylate (8), which lacks the trifluoromethyl group, and methyl crotonate (9), which lacks the three fluoro groups. Previously, we reported that the reaction of 1 and 8 proceeds with a rate constant of k = 1.6 × 10−3 M−1s−1 (Figure 1), which is 102-fold less than that of trifluorocrotonate 2.10 Here, we found the rate constant for cycloaddition with crotonate 9 to be k = 5.8 × 10−7 M−1s −1, which is 105-fold less than that for trifluorocrotonate 2. Notably, the effect of allylic fluorination in this reaction is much larger than is the effect of propargylic fluorination on the cycloaddition of azides (∼400-fold).12d Finally, when added to an equimolar mixture of diazoacetamide 1 and N-benzyl-2-azidoacetamide (10), excess trifluorocrotonate 2 reacted only with diazoacetamide 1, demonstrating chemoselectivity.

Figure 1.

Figure 1

Experimental rate constants and computational parameters of the transition state for cycloadditions of a diazoacetamide with a trifluorocrotonate (12 TS), acrylate (18 TS), and unfluorinated crotonate (19 TS). Optimized geometries, activation energies, distortion/interaction energies, and NBO charges on the dipolarophile (italics) were calculated at the M06-2X/6-31+G(2d,p) level of theory. Energies (kcal/mol) include solvation corrections (water) on gas-phase geometries using IEFPCM model (radii=UFF). The methyl ester of trifluorocrotonate 2 was used to model the ethyl ester. Rate constants were measured in 1:1 CH3CN/H2O (1 + 2; 1 + 8) or CH3CN (1 + 9). Data for the cycloaddition of 1 and 8 were reported previously.10

We employed computational methods to investigate the origin of the increased reactivity of trifluorocrotonate 2. Optimizations were performed with Gaussian 09 software18 at the M06-2X level of theory19 and the 6-31+G(2d,p) basis set. M06-2X has been shown to describe trends in reactivity accurately in other cycloadditions.20 Optimizations were performed in the gas phase, and were followed by single-point solvation corrections. An IEFPCM dielectric continuum solvent model for water with UFF radii was employed. This model does not explicitly include non-electrostatic contributions and should be considered as a first approximation of solvation effects.21 Frequency calculations were performed to confirm stationary points as minima or first-order saddle points (transition state, TS). All ΔE values include zero-point corrections.

Distortion/interaction analysis of the rapid cycloaddition of trifluorocrotonate 2 compared to that for methyl acrylate (8) and the unfluorinated crotonate (9) revealed the origin of the low barrier (Figure 1).22 Relative to the unfluorinated crotonate 9, trifluorocrotonate 2 displays decreased distortion energies for both reacting partners, in addition to significantly larger interaction energies. The increased reactivity over acrylate 8, however, stems not from a decreased distortion energy, as observed for typical cycloadditions of diazoacetamides,10 but from a large increase in interaction energy (ΔEint) that results from an N–H···F–C hydrogen bond formed between the diazoacetamide and a fluoro group of the trifluorocrotonate, along with hyperconjugative assistance to bond formation. Both hydrogen-bond formation12d,23 and hyperconjugative assistance to bond formation have been asserted previously for cycloadditions with azides.12e A key attribute of these interactions is that they are weak or absent in the starting materials, even when the alkene is in the TS geometry, and do not manifest fully until the TS.

NBO analysis24 (Figure 2, Table 1) reveals a small increase (∼4.0 kcal/mol) in key stereoelectronic interactions (e.g., πC=Cσ*C-F, πC=Cπ*C=O) upon going from the starting material (SM) to the distorted alkene. Importantly, a large increase in these interactions is observed in the TS when the diazoacetamide is present. The difference arises because of assistance to bond formation (provided by the carbonyl and allylic C–F bonds12d) and the formation of a N–H···F–C hydrogen bond. The largest increase in NBO interaction energy of 15.2 kcal/mol upon proceeding from the SM to the TS (versus a 10.4 and 10.2 kcal/mol increase for acrylate 8 and unfluorinated crotonate 9, respectively) is in gratifying agreement with the large ΔEint = 15.1 kcal/mol predicted by the distortion analysis. Whereas electronic assistance to bond formation is a direct effect of a lower LUMO, the alternative strategy of employing a remote hydrogen-bonding interaction allows for increased reactivity without sacrificing intrinsic chemoselectivity.

Figure 2.

Figure 2

Orbital overlaps in the transition state for the reaction of diazoacetamide 1 and trifluorocrotonate 2 as calculated at the M06-2X/6-31+G(2d,p) level of theory on gas-phase optimized geometries using IEFPCM (water) solvation corrections. Depictions were generated with NBOView 1.1.

Table 1.

Energies (kcal/mol) from the NBO analysis of stabilizing interactions in trifluorocrotonate 2, acrylate 8, and crotonate 9 in ground state and transition state geometries, and in the full transition state. Energies were calculated at the M06-2X/6-31+G(2d,p) on gas-phase optimized geometries using IEFPCM (water) solvation corrections.

Alkene Type of Interaction Interacting Orbitals SM Distorted Alkene (TS Geometry) TS Δ(TS − SM)
Trifluorocrotonate 2 Conjugative πC=Cπ*C=O 18.5 20.9 26.4 7.9
Hyperconjugative πC=Cσ*C–Fa 12.0 13.5 10.3 −1.7
Hyperconjugative πC=Cσ*C–Fa <0.5 <0.5 7.1 7.1
Hydrogen-bonding nFσ*N–Hb 2.9 2.9
Σ 30.5 34.4 46.7 15.2
Acrylate 8 Conjugative πC=Cπ*C=O 21.8 25.2 32.2 10.4
Σ 21.8 25.2 32.2 10.4
Crotonate 9 Conjugative πC=Cπ*C=O 24.8 28.4 35.3 10.5
Hyperconjugative πC=Cσ*C–Ha 4.9 3.4 2.5 −2.4
Hyperconjugative πC=Cσ*C–Ha <0.5 <0.5 2.1 2.1
Σ 29.7 31.8 39.9 10.2
a

Value is the sum of the interactions of the alkene π-bond with each of the three allylic σ* orbitals.

b

Value is the sum of the interactions of two different lone pairs for a single fluoro group with the N–H σ* at a distance of 2.26 Å (Figure 1).

3. Conclusions

In conclusion, we report on “speed without strain”. The 1,3-dipolar cycloaddition between a stabilized diazo group and a fluorinated crotonate occurs at a reaction rate comparable to that of the fastest SPAAC reactions but requires no activation by strain. Through a computational distortion/interaction analysis, we conclude that the enhanced reactivity results from the development of strong interactions in the transition state, including an N–H···F–C hydrogen bond and hyperconjugation. Diazo compounds can complement azides as biological probes,7 and the insights herein could inspire the de novo design of dipolarophiles tailored for rapid reaction with a diazo group.25

Supplementary Material

supplement

Highlights.

  • Cycloaddition of a diazoacetamide and trifluorocrotonate has a large rate constant.

  • Calculations reveal a hydrogen bond and hyperconjugation in the transition state.

  • Reaction rate is comparable to fastest strain-promoted azide–alkyne cycloadditions.

  • High chemoselectivity exists for the diazoacetamide over an azidoacetamide.

  • Chemoselective reactions in aqueous solution can access “speed” without “strain”.

Acknowledgments

This work was supported by Grant R01 GM044783 (NIH) and made use of the National Magnetic Resonance Facility at Madison, which is supported by Grant P41 GM103399 (NIH). Computational resources were supported in part by Grant CHE-0840494 (NSF). We are grateful to C. L. Jenkins (University of Wisconsin-Madison) for contributive discussions.

Footnotes

Supplementary data: Supplementary data associated with this article can be found, in the online version at http://dx./doi.org/10.1016.j.tetlet.2016.xx.xxx.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References and notes

  • 1.(a) McGrath NA, Andersen KA, Davis AKF, Lomax JE, Raines RT. Chem Sci. 2014;6:752–755. doi: 10.1039/c4sc01768d. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Mix KA, Raines RT. Org Lett. 2015;17:2358–2361. doi: 10.1021/acs.orglett.5b00840. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Zhou W, Hsieh PH, Xu Y, O'Leary TR, Huang X, Liu J. Chem Commun. 2015;51:11019–11021. doi: 10.1039/c5cc02008e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.(a) Antos JM, Francis MB. J Am Chem Soc. 2004;126:10256–10257. doi: 10.1021/ja047272c. [DOI] [PubMed] [Google Scholar]; (b) Antos JM, McFarland JM, Iavarone AT, Francis MB. J Am Chem Soc. 2009;131:6301–6308. doi: 10.1021/ja900094h. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Ho CM, Zhang JL, Zhou CY, Chan OY, Yan JJ, Zhang FY, Huang JS, Che CM. J Am Chem Soc. 2010;132:1886–1894. doi: 10.1021/ja9077254. [DOI] [PubMed] [Google Scholar]; (d) Popp BV, Ball ZT. J Am Chem Soc. 2010;132:6660–6662. doi: 10.1021/ja101456c. [DOI] [PubMed] [Google Scholar]; (e) Popp BV, Ball ZT. Chem Sci. 2011;2:690–695. [Google Scholar]; (f) Chen Z, Popp BV, Bovet CL, Ball ZT. ACS Chem Biol. 2011;6:920–925. doi: 10.1021/cb2001523. [DOI] [PubMed] [Google Scholar]; (g) Chen ZC, Coughlin JM, Stagg LJ, Arold ST, Ladbury JE, Ball ZT. J Am Chem Soc. 2012;134:10138–10145. doi: 10.1021/ja302284p. [DOI] [PubMed] [Google Scholar]; (h) Ball ZT. Acc Chem Res. 2013;46:560–570. doi: 10.1021/ar300261h. [DOI] [PubMed] [Google Scholar]; (i) Ball ZT. Curr Opin Chem Biol. 2015;25:98–102. doi: 10.1016/j.cbpa.2014.12.017. [DOI] [PMC free article] [PubMed] [Google Scholar]; (j) Vohidov F, Coughlin JM, Ball ZT. Angew Chem, Int Ed. 2015;54:4587–4591. doi: 10.1002/anie.201411745. [DOI] [PubMed] [Google Scholar]
  • 3.(a) Tishinov K, Schmidt K, Häussinger D, Gillingham DG. Angew Chem, Int Ed. 2012;51:12000–12004. doi: 10.1002/anie.201205201. [DOI] [PubMed] [Google Scholar]; (b) Tishinov K, Fei N, Gillingham D. Chem Sci. 2013;4:4401–4406. [Google Scholar]; (c) Fei N, Haussinger D, Blumli S, Laventie BJ, Bizzini LD, Zimmermann K, Jenal U, Gillingham D. Chem Commun. 2014;50:8499–8502. doi: 10.1039/c4cc01919a. [DOI] [PubMed] [Google Scholar]
  • 4.(a) Chamni S, He QL, Dang Y, Bhat S, Liu JO, Romo D. ACS Chem Biol. 2011;6:1175–1181. doi: 10.1021/cb2002686. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Josa-Culleré L, Wainman YA, Brindle KM, Leeper FJ. RSC Adv. 2014;4:52241–52244. [Google Scholar]; (c) Friscourt F, Fahrni CJ, Boons GJ. Chem Eur J. 2015;21:13996–14001. doi: 10.1002/chem.201502242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ouihia A, Rene L, Guilhem J, Pascard C, Badet B. J Org Chem. 1993;58:1641–1642. [Google Scholar]
  • 6.(a) Myers EL, Raines RT. Angew Chem, Int Ed. 2009;48:2359–2363. doi: 10.1002/anie.200804689. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Chou H, Raines RT. J Am Chem Soc. 2013;135:14936–14939. doi: 10.1021/ja407822b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Andersen KA, Aronoff MR, McGrath NA, Raines RT. J Am Chem Soc. 2015;137:2412–2415. doi: 10.1021/ja5095815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.(a) Moran J, McKay CS, Pezacki JP. Can J Chem. 2011;89:148–151. [Google Scholar]; (b) Sanders BC, Friscourt F, Ledin PA, Mbua NE, Arumugam S, Guo J, Boltje TJ, Popik VV, Boons GJ. J Am Chem Soc. 2011;133:949–957. doi: 10.1021/ja1081519. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) McGrath NA, Raines RT. Chem Sci. 2012;3:3237–3240. doi: 10.1039/C2SC20806G. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.For recent reviews, see: Lang K, Chin JW. ACS Chem Biol. 2014;9:16–20. doi: 10.1021/cb4009292.Patterson DM, Nazarova LA, Prescher JA. ACS Chem Biol. 2014;9:592–605. doi: 10.1021/cb400828a.Patterson DM, Prescher JA. Curr Opin Chem Biol. 2015;28:141–149. doi: 10.1016/j.cbpa.2015.07.006.
  • 10.Aronoff MR, Gold B, Raines RT. Org Lett. 2016;18:1538–1541. doi: 10.1021/acs.orglett.6b00278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Dommerholt J, van Rooijen O, Borrmann A, Guerra CF, Bickelhaupt FM, van Delft FL. Nat Commun. 2014;5:5378. doi: 10.1038/ncomms6378. [DOI] [PubMed] [Google Scholar]
  • 12.(a) Baskin JM, Prescher JA, Laughlin ST, Agard NJ, Chang PV, Miller IA, Lo A, Codelli JA, Bertozzi CR. Proc Natl Acad Sci USA. 2007;104:16793–16797. doi: 10.1073/pnas.0707090104. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Chenoweth K, Chenoweth D, Goddard WA., III Org Biomol Chem. 2009;7:5255–5258. doi: 10.1039/b911482c. [DOI] [PubMed] [Google Scholar]; (c) Schoenebeck F, Ess DH, Jones GO, Houk KN. J Am Chem Soc. 2009;131:8121–8133. doi: 10.1021/ja9003624. [DOI] [PubMed] [Google Scholar]; (d) Gold B, Shevchenko NE, Bonus N, Dudley GB, Alabugin IV. J Org Chem. 2012;77:75–89. doi: 10.1021/jo201434w. [DOI] [PubMed] [Google Scholar]; (e) Gold B, Dudley GB, Alabugin IV. J Am Chem Soc. 2013;135:1558–1569. doi: 10.1021/ja3114196. [DOI] [PubMed] [Google Scholar]; (f) Garcia-Hartjes J, Dommerholt J, Wennekes T, van Delft FL, Zuilhof H. Eur J Org Chem. 2013;2013:3712–3720. [Google Scholar]
  • 13.(a) O'Hagan D. Chem Soc Rev. 2008;37:308–319. doi: 10.1039/b711844a. [DOI] [PubMed] [Google Scholar]; (b) Honda K, Lopez SA, Houk KN, Mikami K. J Org Chem. 2015;80:11768–11772. doi: 10.1021/acs.joc.5b01361. [DOI] [PubMed] [Google Scholar]
  • 14.Caution! Unstabilized diazo compounds are dangerous, and their use should never be attempted in the context of chemical biology. See: Lewinn EB. Am J Med Sci. 1949;218:556–562.Schoental R. Nature. 1960;188:420–421. doi: 10.1038/188420b0.Lewis CE. J Occup Environ Med. 1964;6:91–92.
  • 15.Jewett JC, Sletten EM, Bertozzi CR. J Am Chem Soc. 2010;132:3688–3690. doi: 10.1021/ja100014q. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.(a) Purser S, Moore PR, Swallow S, Gouverneur V. Chem Soc Rev. 2008;37:320–330. doi: 10.1039/b610213c. [DOI] [PubMed] [Google Scholar]; (b) Hwang CS, Kung A, Kashemirov BA, Zhang C, McKenna CE. Org Lett. 2015;17:1624–1627. doi: 10.1021/ol503765n. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Pollock J, Borkin D, Lund G, Purohit T, Dyguda-Kazimierowicz E, Grembecka J, Cierpicki T. J Med Chem. 2015;58:7465–7474. doi: 10.1021/acs.jmedchem.5b00975. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Gillis EP, Eastman KJ, Hill MD, Donnelly DJ, Meanwell NA. J Med Chem. 2015;58:8315–8359. doi: 10.1021/acs.jmedchem.5b00258. [DOI] [PubMed] [Google Scholar]; (e) Dommerholt J, Rutjes FPJT, van Delft FL. Top Curr Chem. 2016;374:1–20. doi: 10.1007/s41061-016-0016-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Jung ME, Min SJ, Houk KN, Ess D. J Org Chem. 2004;69:9085–9089. doi: 10.1021/jo048741w. [DOI] [PubMed] [Google Scholar]
  • 18.Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery JA, Jr, Peralta JE, Ogliaro F, Bearpark MJ, Heyd J, Brothers EN, Kudin KN, Staroverov VN, Kobayashi R, Normand J, Raghavachari K, Rendell AP, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam NJ, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas Ö, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ. Gaussian, Inc. Wallingford, CT, USA: 2009. [Google Scholar]
  • 19.(a) Zhao Y, Truhlar DG. Acc Chem Res. 2008;41:157–167. doi: 10.1021/ar700111a. [DOI] [PubMed] [Google Scholar]; (b) Zhao Y, Truhlar D. Theoret Chem Acc. 2008;120:215–241. [Google Scholar]
  • 20.Lan Y, Zou L, Cao Y, Houk KN. J Phys Chem A. 2011;115:13906–13920. doi: 10.1021/jp207563h. [DOI] [PubMed] [Google Scholar]
  • 21.(a) Miertuš S, Scrocco E, Tomasi J. Chem Phys. 1981;55:117–129. [Google Scholar]; (b) Tomasi J, Mennucci B, Cancès E. J Mol Struct: THEOCHEM. 1999;464:211–226. [Google Scholar]; (c) Tomasi J, Mennucci B, Cammi R. Chem Rev. 2005;105:2999–3094. doi: 10.1021/cr9904009. [DOI] [PubMed] [Google Scholar]
  • 22.For a tutorial review of the distortion/interaction model (which is also known as the activation strain model), see: Fernández I, Bickelhaupt FM. Chem Soc Rev. 2014;43:4953–4967. doi: 10.1039/c4cs00055b.
  • 23.Bach RD. J Am Chem Soc. 2009;131:5233–5243. doi: 10.1021/ja8094137. [DOI] [PubMed] [Google Scholar]
  • 24.Reed AE, Curtiss LA, Weinhold F. Chem Rev. 1988;88:899–926. [Google Scholar]
  • 25.Conjugate addition by thiols could limit the application of unmodified trifluorocrotonates in biological contexts. See: Karimova NM, Glazkov AA, Ignatenko AV, Kolomiets AF. Russ Chem Bull, Int Ed. 2003;52:1621–1622.Hong V, Kislukhin AA, Finn MG. J Am Chem Soc. 2009;131:9986–9994. doi: 10.1021/ja809345d.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

supplement

RESOURCES